About Fishawack
Fishawack is a company based in Brighton (United Kingdom) founded in 2001 was acquired by Bridgepoint Capital in April 2020. Fishawack has raised $23.59 million across 3 funding rounds from investors including LDC, Bridgepoint Capital and YFM Equity Partners. The company has 45 employees as of March 31, 2020. Fishawack has completed 13 acquisitions, including 2E Creative, Avalere Health and Avalere Health. Fishawack offers products and services including Consulting Services, Data and Technology Services, and Media Services. Fishawack operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
- Headquarter Brighton, United Kingdom
- Employees 45 as on 31 Mar, 2020
- Stage Unicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fishawack Limited
- Date of Incorporation 22 Nov, 2016
- Jurisdiction KNUTSFORD, CHESHIRE, ENGLAND
-
Annual Revenue
$145.17 M (USD)0as on Mar 31, 2019
-
Net Profit
$2.57 K (USD)100as on Mar 31, 2020
-
EBITDA
$3.02 K (USD)100as on Mar 31, 2020
-
Total Equity Funding
$23.59 M (USD)
in 3 rounds
-
Latest Funding Round
$22 M (USD), Series A
Mar 05, 2021
-
Investors
LDC
& 3 more
-
Employee Count
45
as on Mar 31, 2020
-
Investments & Acquisitions
2E Creative
& 12 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fishawack
Fishawack offers a comprehensive portfolio of products and services, including Consulting Services, Data and Technology Services, and Media Services.
Offers expertise in medical policy and access strategies.
Provides data management and evidence analysis for healthcare.
Delivers strategies for healthcare communication and outreach.
People of Fishawack
Unlock access to complete
Software Development Team
75 people
Leadership Team
70 people
Creative and Marketing Team
23 people
Human Resources and Administration
12 people
Sales and Marketing
12 people
Senior Team
12 people
Group Team
6 people
Finance and Accounting
5 people
Unlock access to complete
Funding Insights of Fishawack
Fishawack has successfully raised a total of $23.59M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fishawack
Fishawack has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include LDC, Bridgepoint Capital and YFM Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are focused on multiple sectors for growth.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Private equity firm focused on SMEs
|
Locked | Locked | Locked |
Investor details for Fishawack
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fishawack
Fishawack has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include 2E Creative, Avalere Health and Avalere Health.
Investment portfolio details for Fishawack
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of clinical development and product planning software
|
Locked | Locked | 2015 | Locked | |
|
Biopharma consulting services are provided by Skysis to industry clients.
|
Locked | Locked | 2011 | Locked | |
|
Healthcare marketing services are provided to clients by Carling.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Fishawack
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Fishawack
Detailed financials for Fishawack
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fishawack Comparisons
Peer comparison for Fishawack
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fishawack
Fishawack operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Fishawack
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fishawack
Complete news archive for Fishawack
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fishawack
Fishawack was founded in 2001 and raised its 1st funding round 19 years after it was founded.
Fishawack is headquartered in Brighton, United Kingdom. It is registered at Brighton, East Sussex, United Kingdom.
Fishawack is a funded company, having raised a total of $23.59M across 3 funding rounds to date.
As of Mar 31, 2020, the latest employee count at Fishawack is 45.
Annual revenue of Fishawack is $145.17M as on Mar 31, 2019.
Fishawack was founded in 2001 and is headquartered in Brighton, United Kingdom. Operations focus on the pharmaceutical sector, where fully integrated services are offered across borders to support global organizations. These services encompass strategic consulting, market access, and communications, enabling clients to navigate international regulatory and commercial challenges. The company maintains a presence that facilitates worldwide engagement without regional limitations.
Fishawack's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Fishawack offers Consulting Services, Data and Technology Services, and Media Services.
Fishawack has made 13 acquisitions, including 2E Creative, Avalere Health, and Avalere Health.
Fishawack has 4 investors. Key investors include LDC, Bridgepoint Capital, YFM Equity Partners, and Growth Capital Partners.
The valuation of Fishawack is $4.33B as of Feb 2021.